Clinical Trial Update: A Comparative Double-blind, Double-dummy Study of Desloratadine (DL) 5 mg Once Daily, Cetirizine 10 mg Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (Study P03736) [Phase 4]

View source ↗

Summary

Phase 4 randomized, double-blind, double-dummy study comparing desloratadine 5 mg, cetirizine 10 mg, and placebo in chronic idiopathic urticaria; the study was …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Urticaria

Drugs mentioned

• Cetirizine (cetirizine)
• Desloratadine (desloratadine)

Snippet

Sponsor: Organon and Co | Conditions: Urticaria | Phase 4 | Status: TERMINATED